Fast-acting virus targets melanoma in mice

by Bill Hathaway
Fast-acting virus targets melanoma in mice
The green color shows where the vesicular stomatitis virus has infected rust-colored melanoma tumor cells after injection of the virus into the blood stream. The surrounding non-cancerous tissue is free of virus.

(Medical Xpress)—Yale researchers eradicated most melanoma tumors by exposing them to a fast-acting virus, they report in the June 15 edition of the Journal of Virology.

Melanoma is the deadliest type of and can spread throughout the body and even into the brain.

"After injection into the blood stream of mice, the virus finds melanoma on its own, and is fast and aggressive with tumors," said Anthony N. van den Pol, professor of neurosurgery at Yale School of Medicine, investigator for the Yale Cancer Center and senior author of the study. "Because the virus replicates rapidly, it can kill the melanoma before the immune system responds and kills the virus."

In the process of eliminating the virus, the immune system may also begin to target and kill , he added.

The researchers used the —part of a family of viruses that include rabies and may generate flu-like symptoms in humans. The fast-acting virus ignored healthy melanocytes (the cells from which melanoma arises) but zeroed in on 19 melanoma tumors studied. In 70 percent of tumors tested, melanoma was eradicated completely, while the rest showed a more limited response to the virus.

If safety of the virus can be substantiated, the next target would be to begin trials in humans, van den Pol said.

More information: jvi.asm.org/content/87/2/1019.full

Related Stories

Virus kills melanoma in animal model, spares normal cells

Apr 23, 2013

Researchers from Yale University School of Medicine have demonstrated that vesicular stomatitis virus (VSV) is highly competent at finding, infecting, and killing human melanoma cells, both in vitro and in animal models, ...

Researchers building melanoma vaccine to combat skin cancer

Mar 19, 2012

Mayo Clinic researchers have trained mouse immune systems to eradicate skin cancer from within, using a genetic combination of human DNA from melanoma cells and a cousin of the rabies virus. The strategy, called cancer immunotherapy, ...

Study reveals trigger that may speed melanoma growth

Mar 28, 2012

(HealthDay) -- Growth of the deadly skin cancer melanoma may be triggered by the immune system turning on itself, according to a new study that also identified the mechanism that causes this to happen.

Tumor-killing virus selectively targets diseased brain cells

Feb 19, 2008

New findings show that a specialized virus with the ability to reproduce its tumor-killing genes can selectively target tumors in the brains of mice and eliminate them. Healthy brain tissue remained virtually untouched, according ...

Novel Amgen virus-vaccine shrinks melanoma tumors

Mar 20, 2013

Shares of drugmaker Amgen Inc. are rising on news its innovative melanoma drug, which uses a virus as a Trojan horse to infiltrate and destroy tumors, shrank far more tumors than a standard treatment in a late-stage test.

Recommended for you

Early hormone therapy may be safe for women's hearts

3 hours ago

(HealthDay)—Healthy women at low risk of cardiovascular disease may be able to take hormone replacement therapy soon after menopause for a short time without harming their hearts, according to a new study.

Low yield for repeat colonoscopy in some patients

3 hours ago

(HealthDay)—Repeat colonoscopies within 10 years are of little benefit to patients who had no polyps found on adequate examination; however, repeat colonoscopies do benefit patients when the baseline examination was compromised, ...

Cell's recycling center implicated in division decisions

6 hours ago

Most cells do not divide unless there is enough oxygen present to support their offspring, but certain cancer cells and other cell types circumvent this rule. Researchers at The Johns Hopkins University have now identified ...

User comments